By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis and Genoway said that they have reached an agreement on how to handle orders of products covered by a licensing agreement between the firms that was terminated in late 2008.

In December 2008, Cellectis terminated a non-exclusive license that granted Genoway access to patents covering certain uses of homologous recombination. The initial license had been signed in 2001.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.